Effective management of inherited retinal diseases requires a comprehensive approach to diagnosis and treatment, according to ...

A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...

The Balochistan government has announced expansion of its Cancer and Deadly Diseases Treatment Plan under a public-private partnership between the provincial government and the global pharmaceutical ...

As of November 12, 2025, ProMIS has fully enrolled Cohorts 1 and 2 and is well into Cohort 3, with complete enrollment ...

Phase 1a Single Ascending Dose trial remains on track for initial clinical data to be reportedby year end 2025Phase 1b/2 Multiple Ascending Dose ...

Allergan Aesthetics, an AbbVie company , today announced it will present data highlighting efficacy, safety and patient-reported outcomes across its portfolio during the 2025 American Society of ...

REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...

Kodiak Sciences Inc. , a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that Victor Perlroth, ...

Cohorts 1 and 2 are fully enrolledPMN310 continues to demonstrate a favorable safety profileOn track to report 6-month interim data in Q2 2026 ...

Dharmendra, 89, was admitted to the hospital after facing breathlessness. He is now stable and recovering at home. Here's ...

Acoltremon 0.003% ophthalmic solution significantly increased tear production and improved dry eye disease symptoms in two Phase 3 studies.